Matrix metalloproteinase-9 genetic polymorphisms and the risk for advanced pelvic organ prolapse

Obstetrics and Gynecology

Volumn 120, Issue 3, 2012, Pages 587-593

  Wu, Jennifer M ^a   Visco, Anthony G ^a   Grass, Elizabeth A ^a   Craig, Damian M ^a   Fulton, Rebekah G ^a   Haynes, Carol ^a   Weidner, Alison C ^a   Shah, Svati H ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B;

ADULT; ADVANCED PELVIC ORGAN PROLAPSE; AGE; AGED; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; PARITY; PELVIC ORGAN PROLAPSE; PHENOTYPE; PRIORITY JOURNAL; RACE; SINGLE NUCLEOTIDE POLYMORPHISM; VAGINAL DELIVERY;

AGE FACTORS; AGED; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; GENOTYPING TECHNIQUES; HUMANS; LOGISTIC MODELS; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MULTIVARIATE ANALYSIS; PELVIC ORGAN PROLAPSE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; SEVERITY OF ILLNESS INDEX;

EID: 84865644805     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e318262234b     Document Type: Article

References (32)

1. Hendrix SL, Clark A, Nygaard I, Aragaki A, Barnabei V, McTiernan A. Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity. Am J Obstet Gynecol 2002; 186:1160-6. (Pubitemid 34665053)
2. Subak LL, Waetjen LE, van den Eeden S, Thom DH, Vitting-hoff E, Brown JS. Cost of pelvic organ prolapse surgery in the United States. Obstet Gynecol 2001;98:646-51. (Pubitemid 32907461)
3. Jelovsek JE, Barber MD. Women seeking treatment for advanced pelvic organ prolapse have decreased body image and quality of life. Am J Obstet Gynecol 2006;194:1455-61.
4. Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 1997;89:501-6. (Pubitemid 27133519)
5. Chiaffarino F, Chatenoud L, Dindelli M, Meschia M, Buo-naguidi A, Amicarelli F, et al. Reproductive factors, family history, occupation and risk of urogenital prolapse. Eur J Obstet Gynecol Reprod Biol 1999;82:63-7. (Pubitemid 29042216)
6. McLennan MT, Harris JK, Kariuki B, Meyer S. Family history as a risk factor for pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct 2008;19:1063-9.
7. Nikolova G, Lee H, Berkovitz S, Nelson S, Sinsheimer J, Vilain E, et al. Sequence variant in the laminin gamma1 (LAMC1) gene associated with familial pelvic organ prolapse. Hum Genet 2007;120:847-56. (Pubitemid 46128840)
8. Chen HY, Chung YW, Lin WY, Wang JC, Tsai FJ, Tsai CH. Collagen type 3 alpha 1 polymorphism and risk of pelvic organ prolapse. Int J Gynaecol Obstet 2008;103:55-8.
9. Chen HY, Lin WY, Chen YH, Chen WC, Tsai FJ, Tsai CH. Matrix metalloproteinase-9 polymorphism and risk of pelvic organ prolapse in Taiwanese women. Eur J Obstet Gynecol Reprod Biol 2010;149:222-4.
10. Allen-Brady K, Cannon-Albright L, Farnham JM, Teerlink C, Vierhout ME, van Kempen LC, et al. Identification of six loci associated with pelvic organ prolapse using genome-wide association analysis. Obstet Gynecol 2011;118:1345-53.
11. Word RA, Pathi S, Schaffer JI. Pathophysiology of pelvic organ prolapse. Obstet Gynecol Clin North Am 2009;36:521-39.
12. Budatha M, Roshanravan S, Zheng Q, Weislander C, Chapman SL, Davis EC, et al. Extracellular matrix proteases contribute to progression of pelvic organ prolapse in mice and humans. J Clin Invest 2011;121:2048-59.
13. Moalli PA, Shand SH, Zyczynski HM, Gordy SC, Meyn LA. Remodeling of vaginal connective tissue in patients with prolapse. Obstet Gynecol 2005;106:953-63. (Pubitemid 41532900)
14. Zong W, Stein SE, Starcher B, Meyn LA, Moalli PA. Alteration of vaginal elastin metabolism in women with pelvic organ prolapse. Obstet Gynecol 2010;115:953-61.
15. Hattersley AT, McCarthy MI. What makes a good genetic association study? Lancet 2005;366:1315-23. (Pubitemid 41416588)
16. Hauser ER, Crossman DC, Granger CB, Haines JL, Jones CJ, Mooser V, et al. A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD Study. Am J Hum Genet 2004;75:436-47. (Pubitemid 39095819)
17. Shah SH, Kraus WE, Crossman DC, Granger CB, Haines JL, Jones CJ, et al. Serum lipids in the GENECARD study of coronary artery disease identify quantitative trait loci and phenotypic subsets on chromosomes 3q and 5q. Ann Hum Genet 2006;70:738-48. (Pubitemid 44530638)
18. Lee WC, Wang LY. Reducing population stratification bias: stratum matching is better than exposure. J Clin Epidemiol 2009;62:62-6.
19. Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet 2003;361:598-604. (Pubitemid 36207482)
20. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004;74:106-20. (Pubitemid 38085242)
21. Xu H, Gregory SG, Hauser ER, Stenger JE, Pericak-Vance MA, Vance JM, et al. SNPselector: a web tool for selecting SNPs for genetic association studies. Bioinformatics 2005;21: 4181-6. (Pubitemid 41672110)
22. Meng Z, Zaykin DV, Xu CF, Wagner M, Ehm MG. Selection of genetic markers for association analyses, using linkage disequilibrium and haplotypes. Am J Hum Genet 2003;73: 115-30. (Pubitemid 36793785)
23. de Bakker PI, Yelensky R, Péer I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet 2005;37:1217-23. (Pubitemid 41568704)
24. Gauderman WJ. Sample size requirements for matched case-control studies of gene-environment interaction. Stat Med 2002;21:35-50. (Pubitemid 34065703)
25. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40: 373-83. (Pubitemid 17055592)
26. Tanner RM, Lynch AI, Brophy VH, Eckfeldt JH, Davis BR, Ford CE, et al. Pharmacogenetic associations of MMP9 and MMP12 variants with cardiovascular disease in patients with hypertension. PLoS One 2011;6:e23609.
27. Tesfaigzi Y, Myers OB, Stidley CA, Schwalm K, Picchi M, Crowell RE, et al. Genotypes in matrix metalloproteinase 9 are a risk factor for COPD. Int J Chron Obstruct Pulmon Dis 2006;1:267-78.
28. dbSNP: Short Genetic Variations, rs17576. Available at: www.ncbi.nlm.nih.gov/projects/SNP/snp-ref.cgi?rs = 17576. Retrieved March 13, 2012.
29. Connell KA. Elastogenesis in the vaginal wall and pelvic-organ prolapse. N EnglJ Med 2011;364:2356-8.
30. Northington GM. Fibulin-5: two for the price of one maintaining pelvic support. J Clin Invest 2011;121:1688-91.
31. Dviri M, Leron E, Dreiher J, Mazor M, Shaco-Levy R. Increased matrix metalloproteinases-1,-9 in the uterosacral ligaments and vaginal tissue from women with pelvic organ prolapse. Eur J Obstet Gynecol Reprod Biol 2011;156:113-7.
32. Moon YJ, Choi JR, Jeon MJ, Kim SK, Bai SW. Alteration of elastin metabolism in women with pelvic organ prolapse. J Urol 2011;185:1786-92.